Previous 10 | Next 10 |
home / stock / cslly / cslly news
2023-08-02 06:46:35 ET More on market strategy My Current View Of The S&P 500 Index: August 2023 Edition (Technical Analysis) Avi Gilburt Warns Of Potential Banking Crisis; Charts Indicate Major Disruptions Morgan Stanley bear Wilson sees a 2019-like rally this y...
2023-07-27 09:40:36 ET Summary The news on Starpharma share price is challenging as a significant shareholder exits. The news of commercially interesting developments continues to broaden, meaning that substantial share price upside seems likely. Starpharma has a strong board ...
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season PR Newswire CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older. Since the COVID-19 ...
2023-06-21 05:51:01 ET Summary CSL Limited's FY 2024 profit guidance outlined in a recent announcement last week came in below expectations, and this led to a meaningful correction in its share price. The company's earnings guidance for the new fiscal year was negatively affected ...
CSL Behring Announces the First Patient Has Received FDA-Approved HEMGENIX® (etranacogene dezaparvovec-drlb) for Hemophilia B PR Newswire HEMGENIX ® , the first and only FDA approved gene therapy for hemophilia B, has been proven to elevate and sustain factor IX ...
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure Canada NewsWire Injectafer ® (ferric carboxymaltose) is now the first and only intravenous (i.v.) iron replacement therapy in the U.S. indicated for improvement i...
2023-05-22 17:38:02 ET Summary uniQure secured FDA approval late last year and EMA approval in Q1 2023 for its AMT-061 Hemophilia B treatment. This paves the way for its commercialization in the US and EU. It also has a healthy R&D pipeline, with its Huntington’s diseas...
2023-05-18 05:33:23 ET U.K.'s National Institute for Clinical Excellence (NICE) in its guidance recommended Cara Therapeutics ( NASDAQ: CARA ) and Vifor Fresenius Medical Care Renal Pharma's Kapruvia for use in the National Health Service (NHS). The drug pricing watchdog recomme...
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus Canada NewsWire Recommendation will enable eligible patients in England , Wales and Northern Ireland to access the first license...
2023-05-15 08:26:38 ET Dutch biotech uniQure N.V. ( NASDAQ: QURE ) added ~7% pre-market Monday after announcing an agreement to sell a portion of royalty rights expected to receive from Australian drugmaker CSL Limited ( OTCQX:CSLLY ) in relation to the gene therapy Hemgenix...
News, Short Squeeze, Breakout and More Instantly...
CSL Ltd ADR Company Name:
CSLLY Stock Symbol:
OTCMKTS Market:
CSL Behring Announces Positive Reimbursement Decision in Canada for HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B Canada NewsWire The positive decision from the Canadian Agency for Drugs and Technologies in Health (CADTH) recognizes the im...
CSL Seqirus Begins Shipping Its Portfolio of Influenza Vaccines for the 2024/25 Flu Season PR Newswire CSL Seqirus is the only manufacturer to offer a differentiated influenza vaccine for all eligible people aged six months and older in the United States . Centers for ...
CSL Seqirus, a Proud Champion of Pandemic Preparedness, Announces U.S. Government Award in Response to Avian Influenza PR Newswire CSL Seqirus to complete the fill and finish process for pre-pandemic vaccine to support the U.S. government's outbreak and preparedness response...